Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency
Status:
Recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this phase II trial is to determine the efficacy and safety of testosterone
replacement therapy (TRT) in improving the symptoms of androgen deficiency and health-related
quality of life in men with prostate cancer who have undergone radical prostatectomy.